Study of physical and psychological changes over quality of life in patients of psoriasis

Completed

Conditions: Suffering from skin disease Psoriasis between age group 18 to 70 years

Registration Number: CTRI/2017/02/007843

Lead Sponsor: Department of Skin and VD

Brief Summary: Psoriasis is a chronic papulosquamous disorder characterised by erythematous plaques or papules which may be associated with silvery white scales Aim of my study is to compare and assess the quality of life of the patients of psoriasis which is influenced because of the physical and psychological changes to control The study including 200 patients 100 cases of psoriasis and 100 control will be conducted in the outpatient clinic of the Department of Skin and VD Sir. T Hospital Bhavnagar GujaratA total of 100 patients of psoriasis of both genders and all age groups will be included in the study along with the 100 control which includes the relatives accompanying the patients of psoriasis and other patients attending the clinic but not suffering from psoriasis and the conditions like diabetes and other endocrinal disorders

After obtaining the consent cases and control in this study will be subjected to QOL assessment by questionnaire of Dermatology Life Quality Index DLQI Hospital Anxiety and Depression scale for psychological morbidity investigations like Serum Cholesterol Serum Triglycerides Serum HDL Blood Pressure and height measurement by standard measure tape weight by weighing machine and central obesity by standard measure tape Psoriasis Area and Severity Index PASI will also be calculated of each and every patient

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: All

Target Recruitment: 200

Inclusion Criteria

Patients of age group 18 to 70 years of age and both genders Patients suffering from psoriasis and should not be on biologics and drugs like methotrexate and cyclosporine 3 months before and at the time of participation in the study.

Exclusion Criteria

Patient not willing to participate not giving consent less than 18 years of age pregnant women and patients on biologics and drugs like methotrexate and cyclosporine 3 months before and at the time of participation in the study.

Study & Design

Study Type: Observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Metabolic Syndrome Criteria	0 months
2 Serum Triglycerides 150 mg per dl	0 months
1 Waist Circumference Women 85 cm Men 90 cm	0 months
3 Serum HDL Women 50 mg per dl Men 40 mg per dl	0 months
Dermatology Life Quality Index	0 months
5 Fasting blood sugar more than 126 mg per dl	0 months
Hospital and Anxiety Depression Scale	0 months
4 Blood Pressure 130 by 85 mmhg	0 months

Secondary Outcome Measures

Name	Time	Method
Not applicable	Not applicable

Trial Locations

Locations (1): Sir T Hospital Bhavnagar
🇮🇳
Bhavnagar, GUJARAT, India
Sir T Hospital Bhavnagar
🇮🇳Bhavnagar, GUJARAT, India
Dr Vivek Nimbark
Principal investigator
9429587636
viveknimbark@yahoo.in